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This study was designed to investigate the role of hepatitis C virus (HCV)-induced oxidative stress in 
the pathogenesis of the disease with the measurement of tumor necrosis factor (TNF-) and super 
oxide dismutase (SOD). Eighty patients from Hepatology Unit, Faculty of Medicine, Ain Shams 
University, were investigated. Thirty patients with bilharzial HCV and 30 patients with non-bilharzial 
HCV as compared to 20 healthy controls of the same age and sex ratio were investigated. The 
concentrations of liver enzymes [glutamic oxaloacetic transaminase (GOT), glutamic pyruvic 
transaminase (GPT), alkaline phosphatase (ALP)], bilirubin (Bil), albumin (Alb) and total protein (TP) as 
well as TNF-α and Mn-SOD were determined. The mean level of the different liver function tests in the 
three groups in the study showed that the levels of GOT, GPT and ALP were significantly higher in the 
HCV groups as compared to the control group (p < 0.05). While serum bilirubin, albumin and total 
protein were non-significantly decreased in the HCV groups as compared to the control group (p > 
0.05). Furthermore, the mean level of TNF-α was significantly higher in the HCV groups as compared to 
the control group (p < 0.001) and SOD was significantly decreased in the HCV groups as compared to 
the control group (p < 0.001). There is a cause-effect relationship between increased levels of TNF-α and 
decreased levels of SOD, relative to progression of chronic HCV, especially with bilharzias co-infection. 
Supporting the view that oxidative damage plays a role in chronic HCV infection, also TNF-α establishes 
a positive auto regulatory loop that can amplify the inflammatory response and lead to chronic 
inflammation. More evidence indicates that HCV block apoptosis and prolong survival of the host cell in 
order to gain time for replication and increase viral progeny production. 
  






Hepatitis C virus (HCV) is one of the main causative 
agents of chronic viral hepatitis. Chronic hepatitis C can 
progress to cirrhosis and eventually to hepatocellular 
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mechanisms by which HCV causes cell damage are not 
well understood. Different mechanisms including 
immunological liver damage, direct cytotoxicity mediated 
by different viral product and inductions of oxidative 
stress have been suggested to play a pathogenic role in 
this infection (Boya et al., 1999). A healthy liver is able to 
regenerate most of its own cells when it becomes 
damaged. Tumor necrosis factor (TNF-), is a pleiotropic 
cytokine that can produce oxidative stress by simulating 
the generation of reactive oxygen species (ROS) such as 
superoxide ion (O2
-
) and hydrogen peroxide (H2O2). In the 
liver, TNF- is involved in the pathophysiology of viral 
hepatitis and in the pathogenesis of abnormal 
hepatocellular function (Esteve et al., 2007). 
HCV and schistosoma mansoni has negative impact on  




the course of liver disease. Co-infection leads to a more 
severe clinical courses, higher incidence of cirrhosis and 
poor response to interferon-α (INF-α) therapy. Individuals 
co-infected with HCV and schistomiasis displayed a type 
2-predominance cytokine profile. Also, patients co 
infected with HCV and schistosomiasis exhibit a unique 
clinical, virological and histological pattern manifested by 
viral persistence with high HCV RNA titers, as well as 
higher necroinflammatory and fibrosis scores in their liver 
biopsy samples (Kamal et al., 2000).  
HCV infection is associated with increased oxidative 
stress, which is marked by an increase in oxidants and a 
decrease in antioxidant capacity of the cells (Choi and 
Ou, 2006). Super oxide dismutase (SOD) is considered 
to be a first line of defense
 
against oxidative stress. In 
addition to the contribution by chronic inflammation 
caused by infection, a direct induction of ROS/RNS and 
mitochondrial dysfunction by the virus is likely to occur. 
The role of ROS in liver fibrosis has been suggested by 
the ability of ROS to up-regulate the profibrogenic 
cytokine TGF-β (Packer, 2002). In the infected cells, 
proteins of the HCV core have been shown to augment 
the oxidative and nitrosative stress, lipid peroxidation, 
oxidized thioredoxin and antioxidant gene expression as 
well as to enhance sensitivity to toxins.
 
Reactive oxygen 
species function as inflammatory mediators by activating 
expression of cytokins and therefore ROS may contribute 
to tissue injury by not only directly damaging the tissue 
but also by enhancing further leukocyte accumulation 
(Farinati et al., 2006).
 
HCV is by itself and not only 
through inflammation able to induce ROS, an effect 
specific to this virus (Moriya et al., 2001). This free radical 
production, accompanied by oxidative genomic injury, 
constitutes the first step of a cascade of genomic and 
post genomic events that play an important role in HCC. 
Infection with HCV is associated with increased levels of 
ROS/RNS and decreased antioxidant levels in patients 
(Farinati et al., 2007). 
The aim of the current study was to investigate the role 
of HCV-induced oxidative stress in the pathogenesis of 
the disease with the measurement of TNF-alpha and 
superoxide dismutase. Furthermore, a cause affects 
relationship between TNF-alpha expression and SOD 
release. Finally, correlation of the measured parameters 
with the different clinic pathological factors was studied. 
 
 
MATERIALS AND METHODS 
 
This study was performed using 80 patients admitted at the 
Hepatology Diagnostic Unit, Faculty of Medicine, Ain Shams 
University, Egypt. The Ethical Committee of Faculty of Medicine 
approved this study. Demographic data and medical history were 
obtained at the beginning of the study. The study protocol was 
carried out in accordance with the Helsinki Declaration. All subjects 
were informed about the study and the written consent was 
obtained. Patients with chronic liver diseases were treated by 
supportive treatment as combined diuretics (furosemide [Lasix 40 
mg daily]), (oral spironolactone [Aldactone 100 mg daily, 









Group I  
 
Control group including 20 healthy normal individuals (mean age ± 
SD = 45.35 ±10.6; median age = 43.5 years; range 30 - 65). 
 
 
Group II  
 
Included 30 patients with bilharzial chronic HCV infection (mean 
age ± SD = 48.0 ± 9.47; median age = 45.5 years; range 27 - 65). 
The diagnosis was based on the presence of viable bilharzial ova in 
fecal material as well as serologic testing and liver histopathology. 
 
 
Group III  
 
Included 30 patients with non-bilharzial chronic HCV infection 
(mean age ± SD = 46.3 ± 8.86; median age = 46.5years; range 25 
to 61). The diagnosis was based on a positive test for HCV 
antibodies by third generation Enzyme-linked immunosorbent assay 
(ELISA) and quantitative polymerase chain reaction (PCR) for HCV 
RNA beside clinical, radiological, biochemical (elevated serum 
alanine aminotransferase levels for at least 6 months) and 
histopathological findings. 
All patients were negative for hepatitis B surface antigen and 
Human immunodeficiency virus (HIV), and none had liver cirrhosis 
or renal disease. Other possible causes of hepatocellular injury, 





Ten milliliters of venous blood were withdrawn from each individual 
under complete aseptic conditions and the blood samples were 
divided and put into two tubes. One for serum separation, and the 
other containing anticoagulant for the whole blood. Serum samples 
were separated and stored at -20°C until assayed for aspartate 
transferase, alanine transferase, alkaline phosphatase, total 
bilirubin, total protein, HCV-Ab, bilharzial-Ab and TNF-alpha. While 
whole blood samples were assayed for SOD levels. Liver function 
enzymes (AST, ALT and ALP) were assayed using QCA kits 
(Quimica Clinica Aplicada S.A. kits. Aspartado, Amposta, Spain) 
(Reitman and Frankel, 1957; Belfield and Goldberg, 1971). Total 
protein in serum was determined according to Gornall (1949). HCV 
diagnosis was carried out using ELISA (3rd generation) [Abbott 
laboratories, Chicago, IL USA] (Vrielink et al., 1997). Serum TNF-
alpha levels were measured using ELISA Kit [ASSAYPRO, Assay 
Max Human Tumor Necrosis Factor alpha] (Corti et al., 1992) 
following the procedure recommended by the manufacturers 
(Bender MedSystem, Vienna, Austria). Detection limit was 2.3 
pg/mL for TNF-α. 
 
 
Estimation of SOD activity by ELISA  
 
SOD catalyzes the dismutation of the superoxide radical (O2-) into 
H2O2 and elemental O2, and as such provides an important defense 
against the toxicity of superoxide radicals. Activity of SOD was 
measured according to the instructions from the ELISA reader’s 
supplier. In this assay, O2
-
 that were generated from the conversion 
of xanthine to uric acid and H2O2 by xanthine oxidase (XOD) 
convert WST-1 to WST-1 formazan. SODs in turn reduce 
superoxide ion concentrations and thereby lower the rate of WST-1 
formazan formation. The extent of reduction in the appearance of 
WST-1 formazan is a measure of SOD activity  in  the  experimental  




Table 1. Different liver function in the examined groups. 
 
Parameter Healthy subjects Bilharzial HCV Non Bilharzial HCV 
AST (U/L) 27.85±7.47 64.5±46.77* 80.76±62.7* 
ALT (U/L) 29.5±8.05 56.53±28.8*
§
 92.4±10.42* 
ALP (U/L) 149.4±28.97 229.9±70.71* 241.96±123.18* 
Bilirubin (mg/dl) 0.632±0.201 2.25±0.03 1.188±0.36§ 
Albumin (g/dl) 4.14±0.344 3.95±0.56 4.01±0.41 
Total protein (g/dl) 7.08±0.211 6.94±0.5 6.94±0.43 
 
Data are presented as mean ± SD, *, p <0.05 vs. control, 
§




Table 2. Mean level of SOD and TNF-α in the three examined groups. 
 
Parameter Healthy subjects Bilharzial HCV Non Bilharzial HCV 
SOD(U/ml) 403.9±38.4 204.1±51.35* 229.6±42.4* 
TNF-α (pg/ml) 1.19±0.72 12.05±12.32* 6.15±7.15* 
 




sample. The optical density was measured at 450 nm on an ELISA 
reader (Winterbourne et al., 1975). Serodiagnosis of 
schistosomiasis was done by indirect haemagglutination 
[Schistosomiasis Fumouze] (Doenhoff et al., 1981). 
 
 
Quantitative estimation of viral load 
 
Quantitative estimation of HCV RNA was performed according to 
the instructions from the supplier, and amplification and detection of 
the samples as well as the controls were done using the COBAS 





For patients who gave informed consent and who had pyruvate 
carboxylase activity above 60% (16 patients), ultrasound-guided 
liver biopsy was done by true-cut needle followed by 
histopathological examination of the specimen using haematoxylin 
and eosin, orcein stain, Pert’s stain and periodic acid Schiff stain, 
and examined for staging and grading, according to the methods of 





All analysis were done using the Statistical Package for the Social 
Science (SPSS software version 16, Chicago, Illinois) on a personal 
computer. Data were presented as mean ± SD. Qualitative 
variables were assessed by Chi-square test. Non parametric 
measures were compared by Kruskal-Wallis one way analysis of 
variance with Post Hoc analysis using Mann-Whitney U test. 
Significant levels were P > 0.05 and P<0.00l highly significant. 
Correlation of variables was tested by the Pearson test. Receiver 
operating characteristic (ROC) curves were used to determine the 
threshold value for optimal sensitivity and specificity
 
(Ishak et al., 
1995). And cut-off values were calculated using the standard 





The present work  was  carried  out  on  30  patients  with 
bilharzial HCV, 30 patients non- bilharzial HCV and 20 
healthy persons served as control group. The age of 
subjects ranged from 30 to 65 years in normal healthy 
control group, 27 to 65 years in bilharzial HCV group and 
25 to 61 years in non-bilharzial HCV group. The mean 
age was 45.35 ± 10.6; 46.3 ± 8.86 and 48.0 ± 9.47 years 
in healthy subjects, non- bilharzial HCV group and 
bilharzial HCV group, respectively. The mean levels of 
the different liver enzymes AST, ALT and ALP were 
significantly higher in the HCV groups as compared to the 
control group (p <0.05). While serum bilirubin, albumin 
and total protein showed no statistical significant 
difference (p > 0.05) as shown in Table 1. 
Among HCV groups (Table 2) TNF-α was significantly 
higher when compared with the control group (p <0.001), 
while SOD was significantly decreased (p < 0.001). 
However, no statistical significant difference was found 
on comparing both bilharzial and non-bilharzial HCV 
groups (Figure 1 and Tables 3 to 5).  
The best cut off value of TNF-α was >2.3 pg/ml (area 
under the curve 0.881). Applying this cut off value, the 
overall sensitivity of TNF-α was 75%, and its specificity 
was 95%. The best cut off value of SOD was ≤296 U/ml 
(area under the curve 0.920). Applying this cut off value, 
the overall sensitivity of SOD was 80%, and its specificity 
was 100% as shown in Figure 2. 
The overall sensitivity and specificity of TNF-α at cut off 
>2.3 pg/ml were 80 and 100%, respectively. The 
sensitivity and specificity of SOD at cut off at ≤296 U/ml 
were 75 and 95%, respectively. Furthermore, PPV, NPV 
and accuracy for TNF-α were 100, 62.5 and 77.9%, 
respectively; while for SOD it was 97.8, 55.9 and 90.8%, 
respectively (Table 6). 
The activities of SOD did not correlate with the HCV-
RNA levels. The mean level of SOD was 0.144 ± 0.006 in 
the HCV group as  compared  to  their  respective  control 
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Table 3. TNF-α concentration in the different studied groups. 
 
Group TNF-α (pg/ml) 
a
Normal control (n=20) 
Median 0.98 
Range 0.2 – 3 




Non-bilharzial HCV (n=30) 
Median 3 
Range 0.8 – 35.26 




Bilharzial HCV (n=30) 
Median 4.3 
Range 0.2 – 54.7 
Mean rank 47.60 
 
  
Statistics chi-square = 25.8709, P< 0.0001 
 
P value significant at < 0.05. Non-parametric Kruskal-Wallis test; 
a
Statistically 
significant difference as compared to non-bilharzial HCV group by Mann-Whitney test, 
Z = 5.090, P< 0.0001; 
b
, Statistically significant difference as compared to bilharzial 
HCV group by Mann-Whitney test, Z = 0.651, P = 0.515; 
c
, Statistically significant 





Table 4. Positivity rate of TNF-α in the different studied groups.  
 
Group No. of cases > 2.3 pg/ml (%) No. of cases ≤2.3 pg/ml (%) 
Normal control (n=20) 1 (5%) 19(95%) 
Non-bilharzial HCV (n=30) 21 (70%) 9(30%) 
Bilharzial HCV (n=30) 24 (80%) 6 (20%) 
Statistics X
2 
= 30.691, P = 0.000 
 
Non-parametric chi-square test. 




Table 5. SOD concentration in the different studied groups.  
 
Group SOD (U/ml) 
a
Normal control (n=20) 
Median 400 
Range 318 – 475 
Mean rank 65.70 
b
Non-bilharzial HCV (n=30) 
Median 270 
Range 163 – 424 
Mean rank 25.23 
c
Bilharzial HCV (n=30) 
Median 216 
Range 127 – 410 
Mean rank 38.97 
Statistics chi-square = 36.5990, P < 0.0001 
 
P value significant at <0.05. Non-parametric Kruskal-Wallis test; a, Statistically 
significant difference as compared to non-bilharzial HCV group by Mann-Whitney test, Z 
= 4.487, P < 0.0001; 
b
, Statistically significant difference as compared to bilharzial HCV 
group by Mann-Whitney test, Z = 2.669, P = 0.0076; 
c
, Statistically significant difference 
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Table 6. The overall sensitivity, specificity, PPV, NPV and accuracy of TNF-α and SOD when tested independently (bilharzial and non 
bilharzial HCV versus healthy control). 
 
 Parameter Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%) 
TNF-α 80 100 100 62.5 77.9 









The present work was designed to determine the 
diagnostic accuracy of biomarkers like: TNF-α and Mn-
SOD and correlate levels of biological serum markers 
like: AST, ALT, AP, T. Bil, TP and Alb), in the detection of 
the prognosis and severity of inflammation of liver due to 
HCV mono-infection or when co-infected with 
Schistosoma mansoni. In addition, we attempted to 
establish associations between the investigated 
parameters. In this present study, the  mean  age ± SD of  




the different studied groups was 45.35 ± 10.6 in healthy 
normal, 46.3 ± 8.86 in non-bilharzial HCV group and 48.0 
± 9.47 in bilharzial HCV group (ranged from 30 to 65, 25 
to 61 and 27 to 65 years, respectively). Age at infection 
has been shown to influence the outcome of hepatitis C 
and patients infected after the fourth decade has a higher 
risk of disease progression (El-Zanaty and Way, 2008). 
Conventional liver function tests reflect hepatocytes 
damage as ALT and AST, whereas biliary obstructions 
can be studied by bilirubin and ALP and biosynthetic 
function by albumin and total protein. Although, these 
tests provide important information on some aspects of 
liver function, they do not assess the activity of the 
fibrogenic process, but can indicate the stage of fibrosis 
(Gressner et al., 2007; Rossi et al., 2007). All these 
factors either reflect liver function and/or severity of 
inflammation of liver in the presence of HCV infection 
only or co-infected with schistosomal parasite. In 
comparing the HCV groups with the control group, the 
present work revealed a statistically significant difference 
in the levels of AST, ALT and ALP in HCV groups (p < 
0.01), while no such significant difference was shown 
with serum bilirubin, albumin and total protein. Elevated 
levels of fibrosis serum markers; AST and ALP, in HCV 
patients, both bilharzial and non bilharzial as compared to 
normal control, suggests that these markers could 
differentiate co-infected from the mono-infected patients 
(Shahzad, 2009). In comparing the mean levels of 
different biochemical tests in both HCV groups, it was 
shown that the levels of ALT and bilirubin were 
significantly higher in the bilharzial-HCV group (p < 0.05). 
While serum AST, alkaline phosphatase, albumin and 
total protein showed no statistically significant difference. 
Higher levels of ALT and total bilirubin in HCV patients 
with elevated alpha-fetoprotein (AFP) associated with 
severity of inflammation and advanced fibrosis was also 
shown by Tai et al. (2009). Tumor necrosis factor-alpha 
(TNF-α) is a cytokine that may act as an endogenous 
tumor promoter and is raised 5 to 10 folds during chronic 
inflammatory liver disease. Liver injury is reportedly 
associated with a chronic inflammatory response 
involving TNF-α and interleukin-1b (IL-1b). The former 
plays a central role in liver injury, triggering the 
production of other cytokines that in turn recruit 
inflammatory cells, promote fibrogenesis and further 
activate oxidative burst (Ramadori and Armbrust, 2001). 
The data obtained from our study revealed that TNF-α 
was elevated in the HCV groups when compared with the 
control group with mean levels (1.19 ± 0.72, 12.05 ± 
12.32 and 6.15 ± 7.15) and P < 0.001, in normal, 
bilharzial and non-bilharzial groups, respectively. Most of 
the reported studies (El-Shahat and Kadry, 2009) 
revealed that elevated levels of TNF-α in serum have 
been
 
found in patients with hepatitis C, and correlate with 
the degree of inflammation. A statistically significant 
difference was observed by comparing the levels of TNF-





P < 0.001). Hepatitis C infection is associated with 
increased transcriptional  expression  of  the  TNF-α gene 
in the liver with high serum levels of TNF-α (Larrea et al., 
1996). Activation of TNF-α has a pivotal role in the 
inflammatory process of chronic hepatitis C, and TNF-α 
levels correlate with the degree of inflammation (Stephen 
et al., 2001). In the current study, there was a statistically 
significant difference in the positivity rates of TNF-α. In 
the three studied groups, the positivity rates of TNF-α in 
the voided samples of the control, non-bilharzial HCV and 
bilharzial HCV groups were 1 (5%), 21 (70%) and 24 
(80%), respectively (chi-square = 30.691, P < 0.001). 
These results were in concordance with an Egyptian 
study by Farag et al. (2011). Using ROC curve, the best 
cut off value of TNF-α was 2.3 pg/ml with the overall 
sensitivity of 75%, and specificity of 95%. Patients with 
mild liver inflammation have elevated serum TNF-α 
levels, suggesting that this cytokine could be used as a 
sensitive predictor of liver inflammation (Neuman et al., 
2002). Patients with chronic hepatitis
 
C often exhibit 
increased production of TNF-α, a cytokine that can 
produce oxidative stress by stimulating
 
the release of 
reactive oxygen species (ROS), such as superoxide
 
radical and hydrogen peroxide (Keigo et al., 2006). 
Reactive oxygen species (ROS), such as superoxide, 
hydrogen peroxide and hydroxyl radicals, are produced 
during aerobic metabolism. Thus, oxidative stress has 
emerged as a key player in the development and the 
progression of many pathological conditions, including 
HCV-induced pathogenesis of liver. Our work revealed a 
statistically significant decrease in the mean levels of 
SOD in the HCV groups as compared to the control 
group (P < 0.001). Levels of SOD were significantly 
decreased in chronic hepatitis C patients (Gorenek et al., 
2006). In this study, when comparing both bilharzial and 
non-bilharzial HCV groups, no statistically significant 
differences were observed in the level of SOD. HCV core 
expression does not show a major change in SOD levels, 
suggesting a non-significant impact of core on oxidative 
stress in liver diseases (Wang-Sheng et al., 2000). The 
activities of SOD did not correlate with the HCV-RNA 
levels (Simula and De Re, 2011). Using ROC curve, the 
best cut off value of SOD was ≤296 U/ml with the overall 
sensitivity of SOD 80%, and its specificity 100%. Oxidant 
stress, as reflected in blood by a wide range of pro- and 
anti-oxidant markers, is a significant feature of hepatitis C 
infection (Jain et al., 2002). In the present study, the 
positivity rates of SOD in the voided samples of the 
control, non-bilharzial HCV and bilharzial HCV groups 
were 0 (0%), 22 (73.3%) and 26 (86.7%), respectively 
(chi-square = 36.5990, P < 0.0001). These findings are in 
agreement with that of Farinati et al. (2007). Our study 
demonstrated that SOD decreased, correlating with 
severity of inflammatory process in adults with chronic 
active hepatitis. Also, it was found that SOD activity was 
significantly low in chronic active hepatitis C (CHC) 





SOD levels in CHC patients. The reduction in the amount 
of   SOD   reflects   both   a  decrease  in  the  synthesize 
capacity of liver, and the antioxidant defense power of the 
patients with chronic HCV (Irshad et al., 2002). 
It can be argued that decrease in the antioxidant levels 
may be an early marker of the oxidative stress. Lipid 
peroxides formed can be chemotactic for the neutrophils 
causing increased inflammation, which further drives 
oxidant-mediated injury in the liver (Dikici et al., 2005). 
In the viral hepatitis, virus also infects the peripheral 
lymphocytes. The infected lymphocytes produce 
interferon to stimulate healthy cells against viruses. The 
pathogenetic mechanisms through which HCV causes 
cell damage remain obscure, although it has been 
suggested that the oxidative stress may play a 
pathogenetic role in this infection. The patients with 
chronic hepatitis C exhibit an increased production of 
TNF-α, a cytokine that can produce oxidative stress by 
stimulating the generation of oxygen ROS (Levent et al., 
2006).  
PPV, NPV and accuracy for SOD were 100, 62.5 and 
85%, respectively. In comparing TNF-α and SOD levels 
in chronic HCV patients, we found that overall sensitivity 
and specificity of SOD (80 and 100%, respectively) were 
better than those of TNF-α (75 and 95%). Also, PPV, 
NPV and accuracy for SOD (100, 62.5 and 85%) were 
better than those of TNF-α which were 97.8, 55.9 and 
81.3%, respectively. In conclusion, our study revealed 
that the production of TNF-α in patients with HCV 
infection was accompanied by a reduction in the activity 
of antioxidant enzyme, superoxide dismutase (SOD) 
when compared with healthy control group. Therefore, 
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